Similar articles for PMID: 22379170

Year	Number of Results
1989	1
1994	1
1999	1
2001	2
2002	2
2003	3
2004	4
2005	2
2006	2
2007	3
2008	4
2009	4
2010	8
2011	11
2012	5
2013	11
2014	6
2015	6
2016	3
2017	4
2018	10
2019	8
2021	3
2022	1
2023	2
2024	0

1

Pulmonary hypertension: the science behind the disease spectrum.

Wilkins MR. Wilkins MR. Eur Respir Rev. 2012 Mar 1;21(123):19-26. doi: 10.1183/09059180.00008411. Eur Respir Rev. 2012. PMID: 22379170 Free PMC article. Review.

2

[Pulmonary hypertension: from molecular pathophysiology to haemodynamic abnormalities].

Duong-Quy S, Rivière S, Bei Y, Duong-Ngo C, Le-Dong NN, Hua-Huy T, Dinh-Xuan AT. Duong-Quy S, et al. Rev Mal Respir. 2012 Oct;29(8):956-70. doi: 10.1016/j.rmr.2012.03.009. Epub 2012 Sep 26. Rev Mal Respir. 2012. PMID: 23101638 Review. French.

3

Cellular and molecular pathobiology of pulmonary arterial hypertension.

Humbert M, Morrell NW, Archer SL, Stenmark KR, MacLean MR, Lang IM, Christman BW, Weir EK, Eickelberg O, Voelkel NF, Rabinovitch M. Humbert M, et al. J Am Coll Cardiol. 2004 Jun 16;43(12 Suppl S):13S-24S. doi: 10.1016/j.jacc.2004.02.029. J Am Coll Cardiol. 2004. PMID: 15194174 Free article. Review.

4

New molecular targets of pulmonary vascular remodeling in pulmonary arterial hypertension: importance of endothelial communication.

Guignabert C, Tu L, Girerd B, Ricard N, Huertas A, Montani D, Humbert M. Guignabert C, et al. Chest. 2015 Feb;147(2):529-537. doi: 10.1378/chest.14-0862. Chest. 2015. PMID: 25644906 Review.

5

Relevant issues in the pathology and pathobiology of pulmonary hypertension.

Tuder RM, Archer SL, Dorfmüller P, Erzurum SC, Guignabert C, Michelakis E, Rabinovitch M, Schermuly R, Stenmark KR, Morrell NW. Tuder RM, et al. J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D4-12. doi: 10.1016/j.jacc.2013.10.025. J Am Coll Cardiol. 2013. PMID: 24355640 Free PMC article. Review.

6

Current insights on the pathogenesis of pulmonary arterial hypertension.

Perros F, Dorfmüller P, Humbert M. Perros F, et al. Semin Respir Crit Care Med. 2005 Aug;26(4):355-64. doi: 10.1055/s-2005-916149. Semin Respir Crit Care Med. 2005. PMID: 16121311 Review.

7

Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target.

Kikuchi N, Satoh K, Kurosawa R, Yaoita N, Elias-Al-Mamun M, Siddique MAH, Omura J, Satoh T, Nogi M, Sunamura S, Miyata S, Saito Y, Hoshikawa Y, Okada Y, Shimokawa H. Kikuchi N, et al. Circulation. 2018 Aug 7;138(6):600-623. doi: 10.1161/CIRCULATIONAHA.117.033113. Circulation. 2018. PMID: 29636330

8

Endothelial cell dysfunction and cross talk between endothelium and smooth muscle cells in pulmonary arterial hypertension.

Humbert M, Montani D, Perros F, Dorfmüller P, Adnot S, Eddahibi S. Humbert M, et al. Vascul Pharmacol. 2008 Oct-Dec;49(4-6):113-8. doi: 10.1016/j.vph.2008.06.003. Epub 2008 Jun 20. Vascul Pharmacol. 2008. PMID: 18606248 Review.

9

Pulmonary arterial hypertension and sepsis: prothrombotic profile and inflammation can changes pulmonary mechanics?

Tauil KM, Gaio E, Melo-Silva CA, Carvalho RS, Amado VM. Tauil KM, et al. Med Hypotheses. 2014 Sep;83(3):290-1. doi: 10.1016/j.mehy.2014.05.020. Epub 2014 Jun 7. Med Hypotheses. 2014. PMID: 24957506

10

Inflammation and pulmonary hypertension.

Mathew R. Mathew R. Cardiol Rev. 2010 Mar-Apr;18(2):67-72. doi: 10.1097/CRD.0b013e3181cd612f. Cardiol Rev. 2010. PMID: 20160531 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

102 results

Results by year